High-throughput Antibody & Protein Characterization
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
904
NCT05232474
Using KomPas+ in the Treatment of Patients With Intermittent Claudication
Phase: N/A
Role: Collaborator
Start: Oct 1, 2022
Completion: Feb 28, 2024
Loading map...